Evidence map›Paper›PMID 34009736›Full record

ArticleMicrobial biotechnology2021

A novel toxoflavin-quenching regulation in bacteria and its application to resistance cultivars.

Okhee Choi, Yeyeong Lee, Jiyeong Park, Byeongsam Kang, Hyun Jin Chun, Min Chul Kim, Jinwoo Kim

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Identification of four novelInternational journal of systematic and evolutionary microbiology · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Okhee ChoiInstitute of Agriculture and Life Science, Gyeongsang National University, Jinju, 52828, South Korea.
Yeyeong LeeDepartment of Plant Medicine, Gyeongsang National University, Jinju, South Korea.
Jiyeong ParkDepartment of Plant Medicine, Gyeongsang National University, Jinju, South Korea.
Byeongsam KangDivision of Applied Life Science, Gyeongsang National University, Jinju, South Korea.
Hyun Jin ChunInstitute of Agriculture and Life Science, Gyeongsang National University, Jinju, 52828, South Korea.
Min Chul KimInstitute of Agriculture and Life Science, Gyeongsang National University, Jinju, 52828, South Korea.
Jinwoo KimInstitute of Agriculture and Life Science, Gyeongsang National University, Jinju, 52828, South Korea.ORCID 0000-0003-1104-8088
Gyeongsang National University · KR

Funding

National Research Foundation of Korea 2015R1A6A1A03031413
6 · The paper itself

Abstract

The toxoflavin (Txn), broad host range phytotoxin produced by a variety of bacteria, including Burkholderia glumae, is a key pathogenicity factor of B. glumae in rice and field crops. Two bacteria exhibiting Txn-degrading activity were isolated from healthy rice seeds and identified as Sphingomonas adhaesiva and Agrobacterium sp. respectively. The genes stdR and stdA, encoding proteins responsible for Txn degradation of both bacterial isolates, were identical, indicating that horizontal gene transfer occurred between microbial communities in the same ecosystem. We identified a novel Txn-quenching regulation of bacteria, demonstrating that the LysR-type transcriptional regulator (LTTR) StdR induces the expression of the stdA, which encodes a Txn-degrading enzyme, in the presence of Txn as a coinducer. Here we show that the bacterial StdR

Indexed as

BurkholderiaOryzaEcosystemGene Expression Regulation, BacterialPyrimidinonesQuorum SensingSphingomonasTriazinesPyrimidinonestoxoflavinTriazines

Identifiers

PMID34009736
PMCPMC8313270
OpenAlexW3162578879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.